however, this analysis was conducted in general obesity and diabetes populations, not IBD-specific cohorts, and its findings may not directly translate to patients with underlying intestinal inflammation (97)
Some patients respond very well to GLP-1-based medications and achieve steady weight loss with this approach
Also, experiments conducted in primary islet cells have shown that -arrestin1 restricts the insulin secretion response to GLP1R activation, but not to GIPR activation or tirzepatide
JCI Insight (2020) 5:e140532
In addition, anyone with allergies to GLP-1 receptor agonists should avoid using tirzepatide
The FDA has issued specific warnings about compounded semaglutide and tirzepatide, noting concerns about incorrect ingredients, dosing errors, and quality control issues